Targeted and Untargeted Proteomics

  • Targeted and untargeted proteomics are two major analytical strategies used to investigate proteins in biological systems using mass spectrometry. Both approaches are important in modern proteomics, bioinformatics, molecular biology, medicine, biotechnology, and agricultural research. They differ primarily in their experimental objectives, data acquisition methods, protein identification strategies, and approaches to quantification. Targeted proteomics focuses on measuring predefined proteins or peptides of interest, whereas untargeted proteomics aims to identify and quantify as many proteins as possible within a biological sample without restricting the analysis to a predetermined list. Together, these approaches support protein discovery, biomarker identification, hypothesis testing, biological pathway investigation, and validation of molecular findings.
  • Proteomics involves the large-scale study of proteins expressed by cells, tissues, organs, or organisms under specific biological conditions. Protein abundance and activity can change in response to developmental processes, genetic variation, disease, environmental conditions, nutrition, and physiological stress. Unlike genomic information, which is relatively stable, the proteome is dynamic and influenced by transcription, translation, protein degradation, post-translational modifications, and molecular interactions. Mass spectrometry-based proteomics provides a powerful way to characterize these changes. Targeted and untargeted strategies allow researchers to investigate the proteome from complementary perspectives.
  • Untargeted proteomics, also known as discovery proteomics, aims to identify and quantify a broad range of proteins in a sample without requiring researchers to specify every protein before the experiment. It is particularly useful when the biological changes of interest are not fully understood or when researchers want to discover previously unknown protein differences between experimental groups. For example, an untargeted proteomics study may compare healthy and diseased tissues to identify proteins whose abundance changes during disease development. The resulting data can reveal candidate biomarkers, affected biological pathways, and proteins potentially involved in disease mechanisms.
  • Most large-scale untargeted proteomics studies use bottom-up or shotgun proteomics. In this approach, proteins are extracted from biological samples and digested into peptides using enzymes such as trypsin. The peptide mixtures are separated by liquid chromatography and analysed using tandem mass spectrometry (LC-MS/MS). The mass spectrometer records precursor ion signals and generates fragmentation spectra that provide sequence-related information. Computational algorithms compare the experimental spectra with theoretical spectra derived from protein sequence databases to identify peptides and infer the corresponding proteins.
  • Untargeted proteomics commonly uses data-dependent acquisition (DDA) or data-independent acquisition (DIA). In DDA, the instrument first records a survey mass spectrum and selects a number of precursor ions, usually according to their signal intensities, for fragmentation. This approach provides detailed fragmentation spectra for selected peptides but may fail to consistently analyse low-abundance ions. In DIA, the instrument fragments ions across predefined mass-to-charge ratio (m/z) windows. This produces extensive fragmentation data that can be analysed computationally to identify and quantify many peptides. DIA can offer improved reproducibility and more consistent quantitative coverage across large sample sets, although its complex data require specialized computational analysis.
  • Untargeted proteomics generally involves several stages, beginning with biological sample collection and protein extraction. Proteins are solubilized using suitable buffers, and their concentrations are measured before digestion. Samples may undergo reduction and alkylation to improve digestion efficiency and prevent disulfide bond reformation. Proteins are then enzymatically digested, commonly with trypsin, to produce peptides. After sample cleanup, peptides are separated by liquid chromatography, ionized using electrospray ionization, and analysed by mass spectrometry. The resulting data undergo peptide identification, protein inference, quantification, statistical analysis, and biological interpretation.
  • Quantification in untargeted proteomics may be performed using label-free or labelled approaches. Label-free quantification estimates relative protein abundance using peptide signal intensities or extracted ion chromatograms across samples. Stable isotope labelling by amino acids in cell culture (SILAC) incorporates isotopically labelled amino acids into proteins, allowing samples to be compared through their mass differences. Chemical labelling approaches such as tandem mass tags (TMT) and isobaric tags for relative and absolute quantification (iTRAQ) allow multiple samples to be combined and analysed in a single experiment. These approaches can improve quantitative comparisons, although they require appropriate experimental design, normalization, and statistical evaluation.
  • Targeted proteomics is a hypothesis-driven approach designed to measure predefined proteins or peptides of interest. Instead of attempting to characterize the entire detectable proteome, researchers select specific molecular targets based on previous experiments, biological knowledge, or clinical relevance. Targeted proteomics is particularly useful for validating candidate biomarkers, measuring proteins associated with disease, monitoring signalling pathways, and investigating specific biological processes. For example, after an untargeted study identifies proteins associated with a disease, targeted proteomics can be used to measure those proteins in a larger and independent sample population.
  • Targeted proteomics commonly uses selected reaction monitoring (SRM), multiple reaction monitoring (MRM), and parallel reaction monitoring (PRM). SRM and MRM are generally performed using triple quadrupole mass spectrometers. The first quadrupole selects a specific precursor ion, the second acts as a collision cell to fragment it, and the third selects predefined product ions for detection. In MRM, multiple precursor-to-product ion transitions are monitored during the same analytical run. A transition refers to a specific precursor ion and one of its characteristic product ions. Monitoring several transitions for a peptide improves analytical specificity and helps distinguish the target from interfering signals.
  • PRM is another targeted mass spectrometry approach, commonly performed using high-resolution instruments such as Orbitrap-based systems. In PRM, a specific precursor ion is selected and fragmented, but the instrument records the full product ion spectrum at high resolution rather than monitoring only a limited number of predefined transitions. This provides detailed fragment-ion information and allows researchers to select and evaluate suitable product ions during data analysis. PRM is therefore useful for targeted protein quantification and validation, particularly when high mass accuracy and detailed product ion measurements are required.
  • Targeted proteomics typically begins with the selection of proteins and representative peptides. Peptides should be unique to the protein of interest whenever possible, chemically stable, reproducibly detectable, and suitable for fragmentation. Researchers may select peptides using previous discovery proteomics data, protein sequence information, spectral libraries, and computational prediction tools. Stable isotope-labelled synthetic peptides are often used as internal standards. Because these standards have predictable mass differences from the corresponding endogenous peptides, they can help confirm peptide identity and improve quantitative accuracy. Absolute or highly reliable quantitative measurements may be obtained when appropriate calibration standards and validated analytical procedures are used.
  • Targeted and untargeted proteomics differ in their experimental design and analytical coverage. Untargeted proteomics is primarily designed for discovery and broad protein profiling, while targeted proteomics is designed for sensitive and reproducible measurement of selected molecular targets. Untargeted studies are useful when researchers do not know which proteins will change, whereas targeted studies are appropriate when the proteins of interest are already established. Untargeted approaches generally require extensive computational processing and statistical interpretation, while targeted methods focus on predefined peptide signals and often provide more controlled quantitative measurements.
FeatureUntargeted proteomicsTargeted proteomics
Main objectiveBroad protein discovery and profilingMeasurement of predefined proteins or peptides
Experimental strategyDiscovery-basedHypothesis-driven
Protein selectionNo fixed target list requiredTargets selected before analysis
Common acquisition methodsDDA and DIASRM, MRM and PRM
Typical instrumentsOrbitrap, Q-TOF and other high-resolution systemsTriple quadrupole and high-resolution instruments
Main advantageBroad proteome coverage and discovery of new candidatesSensitive, selective and reproducible measurement
Main limitationComplex data analysis and variable detection of low-abundance proteinsLimited to selected targets
Typical applicationBiomarker discovery and differential proteomicsBiomarker validation and targeted quantification
  • Bioinformatics plays a central role in both strategies. Untargeted proteomics generates large datasets containing thousands of mass spectra, peptide identifications, protein abundance measurements, and experimental features. Computational tools are needed for peak detection, spectrum processing, peptide-spectrum matching, protein inference, normalization, missing-value handling, statistical testing, and pathway analysis. MaxQuant is widely used for peptide and protein identification and quantification, while FragPipe provides workflows based on tools such as MSFragger. Proteome Discoverer supports integrated analysis of mass spectrometry data, and DIA-NN is widely used for DIA data processing. OpenMS provides an open-source framework for developing and executing proteomics workflows.
  • For targeted proteomics, software tools support the selection of peptides, extraction of chromatographic signals, evaluation of transitions, and quantitative analysis. Skyline is widely used for designing and analysing targeted proteomics experiments, including SRM, MRM, and PRM. Spectral libraries and reference datasets can support the selection and confirmation of suitable peptides. Protein sequence resources such as UniProt and NCBI RefSeq provide reference information, while Gene Ontology (GO), KEGG, and Reactome support functional and pathway interpretation. STRING, BioGRID, and IntAct can help investigate interactions among identified proteins.
  • Untargeted proteomics is widely used for biomarker discovery. Researchers can compare protein expression patterns between healthy and diseased individuals, different developmental stages, or distinct experimental conditions. Statistical analysis identifies proteins that show significant changes in abundance, and functional enrichment analysis can reveal affected pathways and biological processes. However, a protein that differs between groups is not automatically a reliable biomarker. Candidate biomarkers must be evaluated for reproducibility, specificity, sensitivity, biological relevance, and performance in independent populations. Targeted proteomics is often used for this validation stage by measuring selected peptides across larger sample collections.
  • The combination of untargeted and targeted proteomics provides a powerful research strategy. Untargeted analysis can identify candidate proteins and generate hypotheses, while targeted analysis can test those hypotheses with greater analytical control. For example, an untargeted LC-MS/MS study may identify proteins associated with inflammation, immune responses, or metabolic changes. Researchers can then select representative peptides from these proteins and develop MRM or PRM assays to measure them in additional samples. This discovery-to-validation workflow is widely used in biomarker research, clinical proteomics, pharmaceutical development, and translational biology.
  • In medicine, untargeted proteomics supports the discovery of disease-associated proteins and pathways, while targeted proteomics can be used to evaluate candidate biomarkers, monitor therapeutic responses, and measure clinically relevant proteins. In pharmaceutical research, these approaches contribute to drug mechanism studies, toxicity assessment, pharmacodynamic analysis, and the characterization of biological medicines. In microbiology, they help investigate microbial protein expression, pathogenicity, stress responses, and host–pathogen interactions.
  • Both strategies also have important applications in agriculture and animal science. Untargeted proteomics can identify proteins associated with growth, feed efficiency, milk production, meat quality, reproductive performance, immune function, and environmental adaptation. Comparative studies can reveal molecular differences between animal breeds, developmental stages, nutritional treatments, and disease conditions. Targeted proteomics can subsequently measure selected proteins across larger animal populations to investigate their relationships with economically important traits. Integration with genomics, transcriptomics, metabolomics, and quantitative genetics can help connect genetic variation with protein expression and observable phenotypes.
  • Despite their advantages, both approaches have limitations. Untargeted proteomics may not detect low-abundance proteins because highly abundant proteins can dominate the analysis. Peptide ionization efficiency, sample preparation, chromatography, and instrument performance can affect protein coverage and quantitative accuracy. Data analysis can be complicated by missing values, false identifications, protein inference ambiguity, and multiple statistical comparisons. Targeted proteomics can provide high analytical specificity, but its coverage is restricted to the selected proteins and peptides. Poor peptide selection, interference from other molecules, and differences in sample matrices can also affect measurements. Both approaches require appropriate experimental design, quality-control samples, internal standards where suitable, technical validation, and statistical evaluation.
  • Targeted and untargeted proteomics are complementary methods that address different research needs. Untargeted proteomics provides broad molecular discovery and helps generate new biological hypotheses, whereas targeted proteomics enables focused and controlled measurement of selected proteins. Their integration creates an effective framework for identifying candidate biomarkers, validating molecular findings, investigating biological pathways, and studying complex phenotypes. Combined with advanced mass spectrometry, computational analysis, biological databases, and multi-omics integration, these approaches are fundamental to modern proteomics and bioinformatics.

Author:

Leave a Reply

Your email address will not be published. Required fields are marked *